1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL CRISPR MARKET BY TYPE
5.1. Introduction
5.2. Class 1
5.3. Class 2
6. GLOBAL CRISPR MARKET BY APPLICATION
6.1. Introduction
6.2. Cell & Gene Therapies
6.3. Disease Diagnostics
6.4. Drug Development
6.5. Others
7. GLOBAL CRISPR MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceuticals & Biotechnology Company
7.3. Academic & Research Institutes
7.4. Others
8. GLOBAL CRISPR MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Taiwan
8.6.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Addgene
10.2. CRISPR Therapeutics
10.3. Editas Medicine
10.4. GenScript Biotech Corporation
10.5. Horizon Discovery (PerkinElmer)
10.6. Integrated DNA Technologies, Inc.
10.7. Intellia Therapeutics, Inc.
10.8. Thermo Fisher Scientific Inc.
10.9. Sigma-Aldrich
10.10. Caribou Biosciences, Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES